Venetoclax is under clinical development by AbbVie and currently in Phase II for Relapsed Acute Myeloid Leukemia.

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

FRANKFURT. Various forms of blood cancer exist – all of which are grouped together under the term leukemia. One common form ...

Recently recognized by the World Health Organization, acute myeloid leukemia (AML) with t(7;12)(q36;p13) has previously been ...

Wife of Syrian ruler was first diagnosed with acute myeloid leukemia in May 2024, a rare and aggressive blood cancer.

With the Oncology Brothers, Uma Borate, MD, discusses how ziftomenib is showing promising results as a targeted therapy for ...

Various forms of blood cancer exist – all of which are grouped together under the term leukemia. One common form of leukemia ...

With the Oncology Brothers, Uma Borate, MD, discusses how CPX-351 demonstrates superior efficacy over 7+3 chemotherapy in ...

Hemogenyx Pharmaceuticals Opens First Clinical Site for HG-CT-1 Phase I Trial Patient Recruitment Begins for CAR-T Cell Therapy Targeting Relapsed/Refractory Acute Myeloid Leukemia in Adults ...

Race Oncology hopes its repurposed drug candidate bisantrene can protect the heart from the dangerous effect of chemotherapy.